Angiography-Derived Index of Microcirculatory Resistance to Define the Risk of Early Discharge in STEMI

Patients with ST-segment-elevation myocardial infarction but no coronary microvascular injury are at low risk of early cardiovascular complications (ECC). We aim to assess whether nonhyperemic angiography-derived index of microcirculatory resistance (NH-IMR ) could be a user-friendly tool to identif...

Full description

Saved in:
Bibliographic Details
Published inCirculation. Cardiovascular interventions Vol. 17; no. 3; p. e013556
Main Authors Scarsini, Roberto, Kotronias, Rafail A, Della Mora, Francesco, Portolan, Leonardo, Andreaggi, Stefano, Benenati, Stefano, Marin, Federico, Sgreva, Sara, Comuzzi, Alberto, Butturini, Caterina, Pesarini, Gabriele, Tavella, Domenico, Channon, Keith M, Garcia Garcia, Hector M, Ribichini, Flavio, Banning, Adrian P, De Maria, Giovanni Luigi
Format Journal Article
LanguageEnglish
Published United States 01.03.2024
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Patients with ST-segment-elevation myocardial infarction but no coronary microvascular injury are at low risk of early cardiovascular complications (ECC). We aim to assess whether nonhyperemic angiography-derived index of microcirculatory resistance (NH-IMR ) could be a user-friendly tool to identify patients at low risk of ECC, potentially candidates for expedited care pathway and early hospital discharge. Retrospective analysis of 2 independent, international, prospective, observational cohorts included 568 patients with ST-segment-elevation myocardial infarction. NH-IMR was calculated based on standard coronary angiographic views with 3-dimensional-modeling and computational analysis of the coronary flow. Overall, ECC (a composite of cardiovascular death, cardiogenic shock, acute heart failure, life-threatening arrhythmias, resuscitated cardiac arrest, left ventricular thrombus, post-ST-segment-elevation myocardial infarction mechanical complications, and rehospitalization for acute heart failure or acute myocardial infarction at 30 days follow-up), occurred in 54 (9.3%) patients. NH-IMR was significantly correlated with pressure/thermodilution-based index of microcirculatory resistance (r=0.607; <0.0001) and demonstrated good accuracy in predicting ECC (area under the curve, 0.766 [95% CI, 0.706-0.827]; <0.0001). Importantly, ECC occurred more frequently in patients with NH-IMR ≥40 units (18.1% versus 1.4%; <0.0001). At multivariable analysis, NH-IMR provided incremental prognostic value to conventional clinical, angiographic, and echocardiographic features (adjusted-odds ratio, 14.861 [95% CI, 5.177-42.661]; <0.0001). NH-IMR <40 units showed an excellent negative predictive value (98.6%) in ruling out ECC. Discharging patients with NH-IMR <40 units at 48 hours after admission would reduce the total in-hospital stay by 943 days (median 2 [1-4] days per patient). NH-IMR is a valuable risk-stratification tool in patients with ST-segment-elevation myocardial infarction. NH-IMR guided strategies to early discharge may contribute to safely shorten hospital stay, optimizing resources utilization.
AbstractList BACKGROUNDPatients with ST-segment-elevation myocardial infarction but no coronary microvascular injury are at low risk of early cardiovascular complications (ECC). We aim to assess whether nonhyperemic angiography-derived index of microcirculatory resistance (NH-IMRangio) could be a user-friendly tool to identify patients at low risk of ECC, potentially candidates for expedited care pathway and early hospital discharge.METHODSRetrospective analysis of 2 independent, international, prospective, observational cohorts included 568 patients with ST-segment-elevation myocardial infarction. NH-IMRangio was calculated based on standard coronary angiographic views with 3-dimensional-modeling and computational analysis of the coronary flow.RESULTSOverall, ECC (a composite of cardiovascular death, cardiogenic shock, acute heart failure, life-threatening arrhythmias, resuscitated cardiac arrest, left ventricular thrombus, post-ST-segment-elevation myocardial infarction mechanical complications, and rehospitalization for acute heart failure or acute myocardial infarction at 30 days follow-up), occurred in 54 (9.3%) patients. NH-IMRangio was significantly correlated with pressure/thermodilution-based index of microcirculatory resistance (r=0.607; P<0.0001) and demonstrated good accuracy in predicting ECC (area under the curve, 0.766 [95% CI, 0.706-0.827]; P<0.0001). Importantly, ECC occurred more frequently in patients with NH-IMRangio ≥40 units (18.1% versus 1.4%; P<0.0001). At multivariable analysis, NH-IMRangio provided incremental prognostic value to conventional clinical, angiographic, and echocardiographic features (adjusted-odds ratio, 14.861 [95% CI, 5.177-42.661]; P<0.0001). NH-IMRangio<40 units showed an excellent negative predictive value (98.6%) in ruling out ECC. Discharging patients with NH-IMRangio<40 units at 48 hours after admission would reduce the total in-hospital stay by 943 days (median 2 [1-4] days per patient).CONCLUSIONSNH-IMRangio is a valuable risk-stratification tool in patients with ST-segment-elevation myocardial infarction. NH-IMRangio guided strategies to early discharge may contribute to safely shorten hospital stay, optimizing resources utilization.
BACKGROUND: Patients with ST-segment–elevation myocardial infarction but no coronary microvascular injury are at low risk of early cardiovascular complications (ECC). We aim to assess whether nonhyperemic angiography-derived index of microcirculatory resistance (NH-IMR angio ) could be a user-friendly tool to identify patients at low risk of ECC, potentially candidates for expedited care pathway and early hospital discharge. METHODS: Retrospective analysis of 2 independent, international, prospective, observational cohorts included 568 patients with ST-segment–elevation myocardial infarction. NH-IMR angio was calculated based on standard coronary angiographic views with 3-dimensional-modeling and computational analysis of the coronary flow. RESULTS: Overall, ECC (a composite of cardiovascular death, cardiogenic shock, acute heart failure, life-threatening arrhythmias, resuscitated cardiac arrest, left ventricular thrombus, post-ST-segment–elevation myocardial infarction mechanical complications, and rehospitalization for acute heart failure or acute myocardial infarction at 30 days follow-up), occurred in 54 (9.3%) patients. NH-IMR angio was significantly correlated with pressure/thermodilution-based index of microcirculatory resistance (r=0.607; P <0.0001) and demonstrated good accuracy in predicting ECC (area under the curve, 0.766 [95% CI, 0.706–0.827]; P <0.0001). Importantly, ECC occurred more frequently in patients with NH-IMR angio ≥40 units (18.1% versus 1.4%; P <0.0001). At multivariable analysis, NH-IMR angio provided incremental prognostic value to conventional clinical, angiographic, and echocardiographic features (adjusted-odds ratio, 14.861 [95% CI, 5.177–42.661]; P <0.0001). NH-IMR angio <40 units showed an excellent negative predictive value (98.6%) in ruling out ECC. Discharging patients with NH-IMR angio <40 units at 48 hours after admission would reduce the total in-hospital stay by 943 days (median 2 [1–4] days per patient). CONCLUSIONS: NH-IMR angio is a valuable risk-stratification tool in patients with ST-segment–elevation myocardial infarction. NH-IMR angio guided strategies to early discharge may contribute to safely shorten hospital stay, optimizing resources utilization.
Patients with ST-segment-elevation myocardial infarction but no coronary microvascular injury are at low risk of early cardiovascular complications (ECC). We aim to assess whether nonhyperemic angiography-derived index of microcirculatory resistance (NH-IMR ) could be a user-friendly tool to identify patients at low risk of ECC, potentially candidates for expedited care pathway and early hospital discharge. Retrospective analysis of 2 independent, international, prospective, observational cohorts included 568 patients with ST-segment-elevation myocardial infarction. NH-IMR was calculated based on standard coronary angiographic views with 3-dimensional-modeling and computational analysis of the coronary flow. Overall, ECC (a composite of cardiovascular death, cardiogenic shock, acute heart failure, life-threatening arrhythmias, resuscitated cardiac arrest, left ventricular thrombus, post-ST-segment-elevation myocardial infarction mechanical complications, and rehospitalization for acute heart failure or acute myocardial infarction at 30 days follow-up), occurred in 54 (9.3%) patients. NH-IMR was significantly correlated with pressure/thermodilution-based index of microcirculatory resistance (r=0.607; <0.0001) and demonstrated good accuracy in predicting ECC (area under the curve, 0.766 [95% CI, 0.706-0.827]; <0.0001). Importantly, ECC occurred more frequently in patients with NH-IMR ≥40 units (18.1% versus 1.4%; <0.0001). At multivariable analysis, NH-IMR provided incremental prognostic value to conventional clinical, angiographic, and echocardiographic features (adjusted-odds ratio, 14.861 [95% CI, 5.177-42.661]; <0.0001). NH-IMR <40 units showed an excellent negative predictive value (98.6%) in ruling out ECC. Discharging patients with NH-IMR <40 units at 48 hours after admission would reduce the total in-hospital stay by 943 days (median 2 [1-4] days per patient). NH-IMR is a valuable risk-stratification tool in patients with ST-segment-elevation myocardial infarction. NH-IMR guided strategies to early discharge may contribute to safely shorten hospital stay, optimizing resources utilization.
Author Della Mora, Francesco
Scarsini, Roberto
Andreaggi, Stefano
Butturini, Caterina
Channon, Keith M
De Maria, Giovanni Luigi
Kotronias, Rafail A
Banning, Adrian P
Pesarini, Gabriele
Benenati, Stefano
Comuzzi, Alberto
Ribichini, Flavio
Sgreva, Sara
Portolan, Leonardo
Tavella, Domenico
Marin, Federico
Garcia Garcia, Hector M
Author_xml – sequence: 1
  givenname: Roberto
  surname: Scarsini
  fullname: Scarsini, Roberto
  organization: Division of Cardiology, Department of Medicine, University of Verona, Italy (R.S., F.D.M., L.P., S.A., S.S., A.C., C.B., G.P., D.T., F.R.)
– sequence: 2
  givenname: Rafail A
  surname: Kotronias
  fullname: Kotronias, Rafail A
  organization: National Institute for Health Research, Oxford Biomedical Research Centre, United Kingdom (R.A.K., S.B., F.M., K.M.C., A.P.B., G.L.D.M.)
– sequence: 3
  givenname: Francesco
  surname: Della Mora
  fullname: Della Mora, Francesco
  organization: Division of Cardiology, Department of Medicine, University of Verona, Italy (R.S., F.D.M., L.P., S.A., S.S., A.C., C.B., G.P., D.T., F.R.)
– sequence: 4
  givenname: Leonardo
  orcidid: 0000-0001-5058-8218
  surname: Portolan
  fullname: Portolan, Leonardo
  organization: Division of Cardiology, Department of Medicine, University of Verona, Italy (R.S., F.D.M., L.P., S.A., S.S., A.C., C.B., G.P., D.T., F.R.)
– sequence: 5
  givenname: Stefano
  orcidid: 0009-0007-6115-5822
  surname: Andreaggi
  fullname: Andreaggi, Stefano
  organization: Division of Cardiology, Department of Medicine, University of Verona, Italy (R.S., F.D.M., L.P., S.A., S.S., A.C., C.B., G.P., D.T., F.R.)
– sequence: 6
  givenname: Stefano
  orcidid: 0000-0001-9669-4278
  surname: Benenati
  fullname: Benenati, Stefano
  organization: National Institute for Health Research, Oxford Biomedical Research Centre, United Kingdom (R.A.K., S.B., F.M., K.M.C., A.P.B., G.L.D.M.)
– sequence: 7
  givenname: Federico
  orcidid: 0000-0001-8776-6647
  surname: Marin
  fullname: Marin, Federico
  organization: National Institute for Health Research, Oxford Biomedical Research Centre, United Kingdom (R.A.K., S.B., F.M., K.M.C., A.P.B., G.L.D.M.)
– sequence: 8
  givenname: Sara
  orcidid: 0000-0002-5867-6340
  surname: Sgreva
  fullname: Sgreva, Sara
  organization: Division of Cardiology, Department of Medicine, University of Verona, Italy (R.S., F.D.M., L.P., S.A., S.S., A.C., C.B., G.P., D.T., F.R.)
– sequence: 9
  givenname: Alberto
  surname: Comuzzi
  fullname: Comuzzi, Alberto
  organization: Division of Cardiology, Department of Medicine, University of Verona, Italy (R.S., F.D.M., L.P., S.A., S.S., A.C., C.B., G.P., D.T., F.R.)
– sequence: 10
  givenname: Caterina
  orcidid: 0000-0001-7666-5293
  surname: Butturini
  fullname: Butturini, Caterina
  organization: Division of Cardiology, Department of Medicine, University of Verona, Italy (R.S., F.D.M., L.P., S.A., S.S., A.C., C.B., G.P., D.T., F.R.)
– sequence: 11
  givenname: Gabriele
  orcidid: 0000-0002-2770-8231
  surname: Pesarini
  fullname: Pesarini, Gabriele
  organization: Division of Cardiology, Department of Medicine, University of Verona, Italy (R.S., F.D.M., L.P., S.A., S.S., A.C., C.B., G.P., D.T., F.R.)
– sequence: 12
  givenname: Domenico
  surname: Tavella
  fullname: Tavella, Domenico
  organization: Division of Cardiology, Department of Medicine, University of Verona, Italy (R.S., F.D.M., L.P., S.A., S.S., A.C., C.B., G.P., D.T., F.R.)
– sequence: 13
  givenname: Keith M
  surname: Channon
  fullname: Channon, Keith M
  organization: National Institute for Health Research, Oxford Biomedical Research Centre, United Kingdom (R.A.K., S.B., F.M., K.M.C., A.P.B., G.L.D.M.)
– sequence: 14
  givenname: Hector M
  orcidid: 0000-0001-5100-0471
  surname: Garcia Garcia
  fullname: Garcia Garcia, Hector M
  organization: Interventional Cardiology, MedStar Washington Hospital Centre (H.M.G.G.)
– sequence: 15
  givenname: Flavio
  orcidid: 0000-0002-6662-0304
  surname: Ribichini
  fullname: Ribichini, Flavio
  organization: Division of Cardiology, Department of Medicine, University of Verona, Italy (R.S., F.D.M., L.P., S.A., S.S., A.C., C.B., G.P., D.T., F.R.)
– sequence: 16
  givenname: Adrian P
  orcidid: 0000-0002-2842-7861
  surname: Banning
  fullname: Banning, Adrian P
  organization: National Institute for Health Research, Oxford Biomedical Research Centre, United Kingdom (R.A.K., S.B., F.M., K.M.C., A.P.B., G.L.D.M.)
– sequence: 17
  givenname: Giovanni Luigi
  orcidid: 0000-0003-3572-1855
  surname: De Maria
  fullname: De Maria, Giovanni Luigi
  organization: National Institute for Health Research, Oxford Biomedical Research Centre, United Kingdom (R.A.K., S.B., F.M., K.M.C., A.P.B., G.L.D.M.)
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38375667$$D View this record in MEDLINE/PubMed
BookMark eNplkF9PwjAUxRujEVG_gumDD74M13Xt1sQXA1OXKCSAvi5ddwvVsWE7jHx7S0BffLonN-fcP78-Om7aBhC6JuGAEE5uh_l0mI_n2fQtG8_zyXg2IBEdhIQyxo_QGRExCRJOo-M_HYc91HfuPQx9m0enqEdTmjDOkzO0uG8Wpl1YuV5ugxFY8wUVzpsKvnGr8YtRtlXGqk0tu9Zu8RSccZ1sFOCuxSPQpvFqCXhq3McukUlbb_HIOLWUdgHYNHg2z17yC3SiZe3g8lDP0etDNh8-Bc-Tx3x4_xwoGtEuoEJVnCsmCU_LksRCaB1rwkMRp1wJlQAkEaOM6yhNSx1DmXAiJGNKVJp4EOfoZj93bdvPDbiuWPlboK5lA-3GFZHwQRYJGnrr3d7qf3TOgi7W1qyk3RYkLHaoi3-oC7-h2KP28avDpk25guov_MuW_gCFaX50
CitedBy_id crossref_primary_10_1161_CIRCINTERVENTIONS_124_013944
crossref_primary_10_3390_jcm13102923
crossref_primary_10_1007_s10554_024_03152_5
Cites_doi 10.1016/j.jacc.2021.09.1379
10.1016/j.jcmg.2018.02.018
10.3389/fcvm.2021.717114
10.1161/CIRCULATIONAHA.112.000298
10.1093/eurheartj/ehv353
10.1016/j.jcmg.2023.01.017
10.4244/EIJ-D-22-00579
10.1093/eurheartj/ehab368
10.1016/j.jcmg.2021.02.023
10.1161/JAHA.116.005409
10.1016/j.jcin.2021.05.027
10.1093/ehjacc/zuab012
10.1093/eurheartj/ehx393
10.1161/CIRCULATIONAHA.108.784215
10.1007/s10554-020-01831-7
10.1007/s10554-021-02254-8
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1161/CIRCINTERVENTIONS.123.013556
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
CrossRef
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
EISSN 1941-7632
EndPage e013556
ExternalDocumentID 10_1161_CIRCINTERVENTIONS_123_013556
38375667
Genre Journal Article
GroupedDBID ---
.XZ
.Z2
0R~
18M
53G
5VS
6J9
AAAAV
AAHPQ
AAIQE
AAJCS
AARTV
AASCR
ABASU
ABBUW
ABDIG
ABJNI
ABVCZ
ABXVJ
ABZAD
ACDDN
ACEWG
ACGFS
ACILI
ACWDW
ACWRI
ACXJB
ACXNZ
ADBBV
ADGGA
ADHPY
ADNKB
AEBDS
AEETU
AFDTB
AFEXH
AFUWQ
AGINI
AHQNM
AHRYX
AHVBC
AINUH
AJIOK
AJNWD
AJNYG
AJZMW
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
BAWUL
BQLVK
C45
CGR
CS3
CUY
CVF
DIK
DIWNM
DUNZO
E.X
E3Z
EBS
ECM
EEVPB
EIF
EJD
EX3
F5P
FCALG
FL-
GNXGY
GQDEL
H13
HLJTE
HZ~
IKREB
IN~
IPNFZ
JF7
KD2
KQ8
KQB
L-C
NPM
O9-
ODMTH
ODZKP
OHYEH
OK1
OPUJH
OUVQU
OVD
OVDNE
OXXIT
P6G
RAH
RHF
RIG
RLZ
S4S
TEORI
TR2
TSPGW
V2I
W2D
W3M
W8F
WOW
ZZMQN
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c323t-39cd66c5a168bb1499ff4f1609486c9c7ee725356f288bf4eb7619a55c9df1123
ISSN 1941-7640
IngestDate Sat Aug 17 05:37:19 EDT 2024
Fri Aug 23 02:06:32 EDT 2024
Sat Nov 02 12:32:05 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords coronary microvascular injury
early discharge
microcirculation
ST-segment–elevation myocardial infarction
coronary angiography
myocardial infarction
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c323t-39cd66c5a168bb1499ff4f1609486c9c7ee725356f288bf4eb7619a55c9df1123
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0009-0007-6115-5822
0000-0001-7666-5293
0000-0001-5100-0471
0000-0001-9669-4278
0000-0002-2770-8231
0000-0002-6662-0304
0000-0001-5058-8218
0000-0002-5867-6340
0000-0002-2842-7861
0000-0003-3572-1855
0000-0001-8776-6647
PMID 38375667
PQID 2928852930
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2928852930
crossref_primary_10_1161_CIRCINTERVENTIONS_123_013556
pubmed_primary_38375667
PublicationCentury 2000
PublicationDate 2024-Mar
2024-03-00
20240301
PublicationDateYYYYMMDD 2024-03-01
PublicationDate_xml – month: 03
  year: 2024
  text: 2024-Mar
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Circulation. Cardiovascular interventions
PublicationTitleAlternate Circ Cardiovasc Interv
PublicationYear 2024
References 38375668 - Circ Cardiovasc Interv. 2024 Mar;17(3):e013944
e_1_3_3_6_2
e_1_3_3_5_2
e_1_3_3_8_2
e_1_3_3_7_2
e_1_3_3_17_2
e_1_3_3_9_2
e_1_3_3_16_2
e_1_3_3_13_2
e_1_3_3_12_2
e_1_3_3_15_2
e_1_3_3_14_2
e_1_3_3_2_2
e_1_3_3_4_2
e_1_3_3_11_2
e_1_3_3_3_2
e_1_3_3_10_2
References_xml – ident: e_1_3_3_6_2
  doi: 10.1016/j.jacc.2021.09.1379
– ident: e_1_3_3_15_2
  doi: 10.1016/j.jcmg.2018.02.018
– ident: e_1_3_3_10_2
  doi: 10.3389/fcvm.2021.717114
– ident: e_1_3_3_13_2
  doi: 10.1161/CIRCULATIONAHA.112.000298
– ident: e_1_3_3_12_2
  doi: 10.1093/eurheartj/ehv353
– ident: e_1_3_3_16_2
  doi: 10.1016/j.jcmg.2023.01.017
– ident: e_1_3_3_11_2
  doi: 10.4244/EIJ-D-22-00579
– ident: e_1_3_3_14_2
  doi: 10.1093/eurheartj/ehab368
– ident: e_1_3_3_4_2
  doi: 10.1016/j.jcmg.2021.02.023
– ident: e_1_3_3_7_2
  doi: 10.1161/JAHA.116.005409
– ident: e_1_3_3_17_2
  doi: 10.1016/j.jcin.2021.05.027
– ident: e_1_3_3_5_2
  doi: 10.1093/ehjacc/zuab012
– ident: e_1_3_3_2_2
  doi: 10.1093/eurheartj/ehx393
– ident: e_1_3_3_3_2
  doi: 10.1161/CIRCULATIONAHA.108.784215
– ident: e_1_3_3_8_2
  doi: 10.1007/s10554-020-01831-7
– ident: e_1_3_3_9_2
  doi: 10.1007/s10554-021-02254-8
SSID ssj0063262
Score 2.4399858
Snippet Patients with ST-segment-elevation myocardial infarction but no coronary microvascular injury are at low risk of early cardiovascular complications (ECC). We...
BACKGROUND: Patients with ST-segment–elevation myocardial infarction but no coronary microvascular injury are at low risk of early cardiovascular complications...
BACKGROUNDPatients with ST-segment-elevation myocardial infarction but no coronary microvascular injury are at low risk of early cardiovascular complications...
SourceID proquest
crossref
pubmed
SourceType Aggregation Database
Index Database
StartPage e013556
SubjectTerms Coronary Angiography
Coronary Vessels - diagnostic imaging
Heart Failure - etiology
Humans
Microcirculation
Myocardial Infarction - diagnostic imaging
Myocardial Infarction - etiology
Myocardial Infarction - therapy
Patient Discharge
Percutaneous Coronary Intervention - adverse effects
Prospective Studies
Retrospective Studies
ST Elevation Myocardial Infarction - diagnostic imaging
ST Elevation Myocardial Infarction - etiology
ST Elevation Myocardial Infarction - therapy
Treatment Outcome
Title Angiography-Derived Index of Microcirculatory Resistance to Define the Risk of Early Discharge in STEMI
URI https://www.ncbi.nlm.nih.gov/pubmed/38375667
https://search.proquest.com/docview/2928852930
Volume 17
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwELWWIiEuCMTXUkBG6jUhH7aTHKvdohZEJZYt6i2KE7vKJak2WYT4Z_y7ztipN1uWqvQSrSLFcTxvx2_sN2NCDlIsoSKCwmNpoD3GAulJXQReEvFUqrCSOsZs5K-n4viMfT7n55PJn5Fqad1Lv_y9M6_kPlaFe2BXzJL9D8u6RuEG_Ab7whUsDNc72fiwuaiHktPeHF74U6G2t1K_jLAFpXZlvUKhqdlJX6gOySL-k4FwzpVGgom8czHIy22x43ndmfJJpprI9yXYaUxgZ0OD8E0-qkW2xKwj_aSj6rjD09Xm4KhBxt06J9-aA3hsStmi0EUNcPEdtUZdFvgccxCSPQBEdaV7GCWwEJbbzAkF8cSqasdLGBHbaLgGr5ux0EuErdvkq_G9eNtVJyNIxrtnAIEzwOxkMTM1hX8cnZp0bB9maB_oLuc7Cm_fmBCdTNEESCLM_2oth9Zy29oD8jACH4fO9cs3t4EF_TZn2bove0QOht59vK1v2-zoHyGPoT7Lp-TJELPQQwvAZ2SimufkYgf4qAEfbTW9CT66AR_tW2rBRwF8FMGHTxjwUQc-WjfUgO8FOft0tJwde8OpHV4ZR3HvxVlZCVHyIhSplBCAZ1ozHYogY6koszJRChxBzIWO0lRqpiSupBWcl1mlgf3HL8le0zbqNaEJxDKaxUnFhGKZFGmB-9oylRCXFDLSU8KvRyu_tMVZ8rvYbEo-XA9tDt4Ut8iKRrXrLo8y6BQHChxMySs75q5lXMuB4Cd5c8-37pPHG_C_JXv9aq3eAaPt5XuDnSu36p5j
link.rule.ids 315,783,787,27936,27937
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Angiography-Derived+Index+of+Microcirculatory+Resistance+to+Define+the+Risk+of+Early+Discharge+in+STEMI&rft.jtitle=Circulation.+Cardiovascular+interventions&rft.au=Scarsini%2C+Roberto&rft.au=Kotronias%2C+Rafail+A.&rft.au=Della+Mora%2C+Francesco&rft.au=Portolan%2C+Leonardo&rft.date=2024-03-01&rft.issn=1941-7640&rft.eissn=1941-7632&rft.volume=17&rft.issue=3&rft_id=info:doi/10.1161%2FCIRCINTERVENTIONS.123.013556&rft.externalDBID=n%2Fa&rft.externalDocID=10_1161_CIRCINTERVENTIONS_123_013556
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1941-7640&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1941-7640&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1941-7640&client=summon